Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anaïs Vallet

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|January 2, 2007
Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patientsVincent Mallet, Pierre Blanchard, Virginie Verkarre, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 16, 2008
Influence of liver biopsy on abstinence in alcohol-dependent patientsJean-Baptiste Trabut, Arnaud Plat, Véronique Thepot, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 8, 2018
Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipientsStanislas Pol, Olivier Marion, Anaïs Vallet-Pichard, et al.
European Journal of Gastroenterology & Hepatology|February 13, 2009
Acute cholestatic hepatitis revealing Mycoplasma pneumoniae infection without lung involvement in an adult patientJean-Jacques Quioc, Jean-Baptiste Trabut, François Drouhin, et al.
Neural Development|March 15, 2019
Timing the spinal cord development with neural progenitor cells losing their proliferative capacity: a theoretical analysisManon Azaïs, Eric Agius, Stéphane Blanco, et al.
Antiviral Therapy|October 13, 2005
The impact of haematopoietic growth factors on the management and efficacy of antiviral treatment in patients with hepatitis C virusPascal Lebray, Bertrand Nalpas, Anaïs Vallet-Pichard, et al.
Hepatology (Baltimore, Md.)|June 15, 2007
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestAnaïs Vallet-Pichard, Vincent Mallet, Bertrand Nalpas, et al.
Journal of Clinical Medicine|June 10, 2023
Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive StudyLucia Parlati, Kennie Marcin, Benoit Terris, et al.
Antiviral Therapy|February 2, 2012
The role of adherence in virological suppression in patients receiving anti-HBV analoguesPhilippe Sogni, Maria Patrizia Carrieri, Hélène Fontaine, et al.
Plos Computational Biology|March 23, 2026
Sensitivity analysis enlightens effects of connectivity in a Neural Mass Model under Control-Target modeAnaïs Vallet, Stéphane Blanco, Coline Chevallier, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|January 2, 2007
Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patientsVincent Mallet, Pierre Blanchard, Virginie Verkarre, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 16, 2008
Influence of liver biopsy on abstinence in alcohol-dependent patientsJean-Baptiste Trabut, Arnaud Plat, Véronique Thepot, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 8, 2018
Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipientsStanislas Pol, Olivier Marion, Anaïs Vallet-Pichard, et al.
European Journal of Gastroenterology & Hepatology|February 13, 2009
Acute cholestatic hepatitis revealing Mycoplasma pneumoniae infection without lung involvement in an adult patientJean-Jacques Quioc, Jean-Baptiste Trabut, François Drouhin, et al.
Neural Development|March 15, 2019
Timing the spinal cord development with neural progenitor cells losing their proliferative capacity: a theoretical analysisManon Azaïs, Eric Agius, Stéphane Blanco, et al.
Antiviral Therapy|October 13, 2005
The impact of haematopoietic growth factors on the management and efficacy of antiviral treatment in patients with hepatitis C virusPascal Lebray, Bertrand Nalpas, Anaïs Vallet-Pichard, et al.
Hepatology (Baltimore, Md.)|June 15, 2007
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestAnaïs Vallet-Pichard, Vincent Mallet, Bertrand Nalpas, et al.
Journal of Clinical Medicine|June 10, 2023
Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive StudyLucia Parlati, Kennie Marcin, Benoit Terris, et al.
Antiviral Therapy|February 2, 2012
The role of adherence in virological suppression in patients receiving anti-HBV analoguesPhilippe Sogni, Maria Patrizia Carrieri, Hélène Fontaine, et al.
Plos Computational Biology|March 23, 2026
Sensitivity analysis enlightens effects of connectivity in a Neural Mass Model under Control-Target modeAnaïs Vallet, Stéphane Blanco, Coline Chevallier, et al.
Pageof 6